HZNP Finance Ltd. v. Actavis Laboratories UT, Inc.

 
DOCKET NO.
OP. BELOW
SUBJECT
Patent

Question(s) Presented

“Whether the ‘basic and novel properties’ identified in connection with a patent claim’s transitional phrase ‘consisting essentially of’ must independently satisfy the requirements of 35 U.S.C. § 112, ¶ 2, of the Patent Act, and the accompanying ‘reasonable certainty’ standard set forth in Nautilus, Inc. v. Biosig Instruments Inc., 134 S. Ct. 2120 (2014).”

Posts About this Case

Date
Proceedings and Orders
August 19, 2020
DISTRIBUTED for Conference of 9/29/2020.
August 31, 2020
Response Requested. (Due September 30, 2020)